Selected artemisinin dimers for the treatment of lashmaniasis
US12156915B2 · kind B2 · utility
0Cited by
3References
3Claims
0Family size
Inventors
Key dates
| Filing date | Feb 25, 2020 |
| Grant date | Dec 3, 2024 |
| Priority date | — |
| Expiry date | Aug 9, 2041 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
New compositions are provided containing artemisinin dimers with high activity as anti-protozoal agents, including anti-malarial and anti-leishmanial properties, and methods for the treatment of protozoal infections, including malaria or leishmaniasis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.